As part of a massive nationwide effort, ISB is leading a multi-site consortium for the NIH RECOVER (Researching COVID to Enhance Recovery) Initiative. The Pacific Northwest consortium is made up of ISB, Providence, Swedish, and University of Washington School of Medicine.
From planning, creating and executing workshops for educators to forging new relationships to elevate students, the ISB Education team has been in high gear. Each month throughout the 2021-2022 academic year, we will highlight some of the top projects the team is working on.
Dr. Jim Heath was announced as a newly elected Fellow of the American Academy for Cancer Research (AACR) Academy Class of 2022. “I am honored and humbled to be recognized as part of this renowned group of researchers who have done so much to move our understanding of cancer forward,” Heath said.
A message to Ukrainian scientists Institute for Systems Biology expresses our solidarity with Ukraine. We are saddened by the invasion of Ukraine, and our thoughts are with those in affected regions. We highly encourage Ukrainian scientists to consider career opportunities in research at ISB, and we will give careful consideration to any who apply. It is our hope that peace is reclaimed in Ukraine and that a healthy, prosperous, sustainable…
In the first ISB-Town Hall Seattle Science Series of 2022, ISB President Dr. Jim Heath sat down with New York Times Pulitzer Prize winning reporter and bestselling author Matt Richtel for a wide ranging discussion that touched on the incredible immune system, distracted driving, social isolation, and much more.
Who is most likely to suffer from long COVID? In this PBS NewsHour segment, William Brangham interviews Swedish’s Dr. Jason Goldman, an author and collaborator on the ISB-led study on long COVID published in the journal Cell.
In an article published by Sumathi Reddy for the Wall Street Journal titled, “The New Clues About Who Will Develop Long Covid ,” findings of an ISB-led study published in the journal Cell are covered, along with two complementary Long Covid studies conducted by other research organizations.
In an article published by Pam Belluck for the New York Times titled, “New Research Hints at 4 Factors That May Increase Chances of Long Covid,” findings of an ISB-led study published in the journal Cell are covered in depth, including quotes from ISB president Dr. Jim Heath.
Researchers have identified several factors that can be measured at the initial point of COVID-19 diagnosis that anticipate if a patient is likely to develop long COVID. They also found that mild cases of COVID-19, not just severe cases, are associated with long COVID. Their findings were published by the journal Cell.
An ISB-led study examined the electronic health records of more than 18,000 people with SARS-CoV-2 tests during pregnancy, and found that those who contracted COVID-19 while pregnant were more likely to have poor birth outcomes including preterm birth, small for gestational age, low birth weight, and stillbirth.
Dr. Anna Kuchina has joined ISB as assistant professor, and is our newest faculty member. Kuchina comes to ISB after completing her postdoctoral training in the Seelig Lab at the University of Washington. In this Q&A, we delve into Kuchina’s research career to date, her research areas of interest, and much more.
This past fall, AmeriCorps member Miranda Johnson packed her bags and left her home state of Illinois to join ISB as a Systems Thinkers in STEM Coordinator. Johnson is the first AmeriCorps member at ISB, so we had quite a few questions about how she got here, her experience thus far, and her future plans.
The quest to create cultivated meat has been a true multidisciplinary puzzle. It’s biology, engineering, physics, bioinformatics, mathematics, computer science, and more. Enter systems biology. ISB and other organizations are toiling to better understand how to create lab-grown meat in a safe, effective manner that can eventually scale up to compete with traditional meat.
Tuberculosis (TB) is the world’s second leading infectious disease killer after COVID-19. Drug resistance to TB is a public health crisis. ISB researchers have developed algorithms to predict the efficacy of drugs in treating Mycobacterium tuberculosis (MTB), the causative agent for TB. These research findings were published in the journal Cell Reports Methods.
In the final ISB-Town Hall Seattle Science Series of 2021, ISB Assistant Professor Dr. Sean Gibbons sat down with UCSD Professor Dr. Jack Gilbert, and the two microbiome experts discussed past research, exciting science happening today, promising products and therapies on the horizon, and much more.
More than 300 people registered for Reimagine: Your Immune System, ISB’s annual virtual fundraiser, for an evening that included guest appearances Nobel laureate Dr. David Baltimore, immunology expert Dr. Mark Davis, ISB President Dr. Jim Heath, and a host of ISB researchers studying the human immune system.
Longevity and aging researcher Dr. Nir Barzilai participated in a fireside chat conversation with ISB Co-founder and Professor Dr. Lee Hood. The two renowned scientists talked about Barzilai’s study of 750 centenarians, how aging research has changed over the years, and what exciting developments are coming.
By taking detailed measurements of blood and other biological samples, ISB scientists have shown they can identify markers for cancer years before diagnosis. This was the topic of a recent Research Roundtable presentation delivered by Dr. Andrew Magis, Director of Data Science in ISB’s Health Data Science Lab.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.